142 related articles for article (PubMed ID: 9159261)
1. Potential role of growth factors in ovarian cancer.
Jassoni VM; Amadori A; Gentile G; Alesi L
Front Biosci; 1996 Dec; 1():g14-9. PubMed ID: 9159261
[TBL] [Abstract][Full Text] [Related]
2. The role of peptide growth factors in epithelial ovarian cancer.
Berchuck A; Olt GJ; Everitt L; Soisson AP; Bast RC; Boyer CM
Obstet Gynecol; 1990 Feb; 75(2):255-62. PubMed ID: 2300354
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
4. [Growth factors in epithelial ovarian cancer].
Piccinno R; Puopolo M; Rigault De La Longrais IA; Fracchioli S; Massobrio M; Katsaros D
Minerva Ginecol; 2002 Feb; 54(1):33-52. PubMed ID: 11828269
[TBL] [Abstract][Full Text] [Related]
5. [Growth regulation of human ovarian cancer cells by growth factors in vitro].
Chen X; Gao Y; Sun Y
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):740-3. PubMed ID: 9387517
[TBL] [Abstract][Full Text] [Related]
6. Role of growth factors and their receptors in the control of normal cell proliferation and cancer.
Wahl MI; Carpenter G
Clin Physiol Biochem; 1987; 5(3-4):130-9. PubMed ID: 3040317
[TBL] [Abstract][Full Text] [Related]
7. Telomerase prolongs the lifespan of normal human ovarian surface epithelial cells without inducing neoplastic phenotype.
Alvero AB; Fishman DA; Qumsiyeh MB; Garg M; Kacinski BM; Sapi E
J Soc Gynecol Investig; 2004 Dec; 11(8):553-61. PubMed ID: 15582501
[TBL] [Abstract][Full Text] [Related]
8. Growth regulation of ovarian cancer.
Godwin AK; Perez RP; Johnson SW; Hamaguchi K; Hamilton TC
Hematol Oncol Clin North Am; 1992 Aug; 6(4):829-41. PubMed ID: 1500388
[TBL] [Abstract][Full Text] [Related]
9. The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium.
Dabrow MB; Francesco MR; McBrearty FX; Caradonna S
Gynecol Oncol; 1998 Oct; 71(1):29-37. PubMed ID: 9784315
[TBL] [Abstract][Full Text] [Related]
10. Transformation-related growth factors and their receptors.
Bregman MD; Sipes NJ
Int J Cell Cloning; 1986 Jul; 4(4):224-36. PubMed ID: 3018097
[TBL] [Abstract][Full Text] [Related]
11. Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.
Rodriguez GC; Haisley C; Hurteau J; Moser TL; Whitaker R; Bast RC; Stack MS
Gynecol Oncol; 2001 Feb; 80(2):245-53. PubMed ID: 11161867
[TBL] [Abstract][Full Text] [Related]
12. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
Jones MB; Michener CM; Blanchette JO; Kuznetsov VA; Raffeld M; Serrero G; Emmert-Buck MR; Petricoin EF; Krizman DB; Liotta LA; Kohn EC
Clin Cancer Res; 2003 Jan; 9(1):44-51. PubMed ID: 12538450
[TBL] [Abstract][Full Text] [Related]
13. Growth regulation of ovarian cancer cell line HO-8910 by transforming growth factor beta 1 in vitro.
Chen X; Zheng S; Gao Y; Dai H; Mou H; Yang H
Chin Med J (Engl); 1998 Jun; 111(6):546-50. PubMed ID: 11245077
[TBL] [Abstract][Full Text] [Related]
14. Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor.
Honma Y; Nishida K; Sotozono C; Kinoshita S
Exp Eye Res; 1997 Sep; 65(3):391-6. PubMed ID: 9299175
[TBL] [Abstract][Full Text] [Related]
15. [Expression of aFGF and bFGF in ovarian cancer and their effect on ovarian cancer cell proliferation].
Zhang Y; Shang H; Sun LG; Liu N; Yu HY
Ai Zheng; 2003 Nov; 22(11):1162-5. PubMed ID: 14613644
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm.
Ahmed N; Thompson EW; Quinn MA
J Cell Physiol; 2007 Dec; 213(3):581-8. PubMed ID: 17708542
[TBL] [Abstract][Full Text] [Related]
17. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.
Collino F; Revelli A; Massobrio M; Katsaros D; Schmitt-Ney M; Camussi G; Bussolati B
Exp Cell Res; 2009 Oct; 315(17):2982-94. PubMed ID: 19538958
[TBL] [Abstract][Full Text] [Related]
19. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CHP2 enhances tumor cell growth, invasion and metastasis in ovarian cancer.
Jin Q; Kong B; Yang X; Cui B; Wei Y; Yang Q
In Vivo; 2007; 21(4):593-8. PubMed ID: 17708351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
